Literature DB >> 6403081

Failure of regulation of Tac antigen/TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody.

M Tsudo, T Uchiyama, H Uchino, J Yodoi.   

Abstract

Anti-Tac monoclonal antibody, which blocks the membrane binding and action of human T-cell growth factor (TCGF), is strongly proposed to recognize TCGF receptor. We have demonstrated that anti-Tac antibody reacted with leukemic cells from patients with adult T-cell leukemia (ATL) and reacted with T-cell lines established from ATL cells. Although antigenic modulation, or down-regulation, of Tac antigen on activated normal T cells was induced by anti-Tac antibody, the expression of Tac antigen on ATL cells or T-cell lines was not affected when examined by the fluorescence-activated cell sorter (FACS) and the radioassay using 125I-staphylococcal protein A. These results indicate that regulation of Tac antigen-TCGF receptor is different between normal and malignant T cells, suggesting that failure of down-regulation of Tac antigen on leukemic cells by anti-Tac antibody may play an important role in the malignant proliferation of ATL cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403081

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus.

Authors:  Y Tokano; A Murashima; Y Takasaki; H Hashimoto; K Okumura; S Hirose
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

2.  Phenotypic evolution of CTL B-lines in vitro.

Authors:  M Février; C Foa; J Simonetti; C Prevot; M Barad; M Berebbi
Journal:  Br J Exp Pathol       Date:  1987-04

3.  Molecular cloning and structure of the human interleukin 2 receptor gene.

Authors:  N Ishida; H Kanamori; T Noma; T Nikaido; H Sabe; N Suzuki; A Shimizu; T Honjo
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

4.  Effect of HTLV-III on the macromolecular synthesis in HTLV-I carrying cell line, MT-4.

Authors:  H Nakashima; Y Koyanagi; S Harada; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

5.  Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence.

Authors:  A Shimuzu; S Kondo; S Takeda; J Yodoi; N Ishida; H Sabe; H Osawa; T Diamantstein; T Nikaido; T Honjo
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

6.  Constitutive IL-2 expression in HTLV-I-infected leukaemic T cell lines.

Authors:  J P Farcet; F Lebargy; C Lavignac; P Gaulard; A Dautry; L Gazzolo; P H Roméo; W Vainchenker
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

7.  Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.

Authors:  J Hayashi; Y Kishihara; K Yamaji; E Yoshimura; M Ohmiya; Y Tani; H Ikematsu; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus.

Authors:  S Sawada; H Hashimoto; S Iijma; Y Tokano; Y Matsukawa; M Takei; H Ishikawa; H Kang; K Tomura; K Mitamura
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

9.  Interleukin 1 gene expression in adult T cell leukemia.

Authors:  Y Wano; T Hattori; M Matsuoka; K Takatsuki; A O Chua; U Gubler; W C Greene
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

10.  Retrovirus-induced expression of interleukin 2 receptors on cells of human B-cell lineage.

Authors:  K Sugamura; M Fujii; N Kobayashi; M Sakitani; M Hatanaka; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.